From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Okyo Pharma – after the pump and dump now its a share support operation ahead of next bailout fund raise just weeks away

By Tom Winnifrith | Wednesday 29 March 2023


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Heaven knows why this US based POS maintains a dual listing on the (sub) Standard List. It really is a cash guzzling crock as we have pointed out on numerous occasions HERE. In the first part of this year Okyo Pharma (OKYO) managed to pump its shares up to 5.5p with a series of spurious and ramptastic RNS’s. Then as the Bulletin Board Morons took they trousers down, whoosh, a $5.5 million funding arranged by the company not its brokers, came in at just 1.85p. Ouch. And double ouch. One hopes that the morons had lubed up.
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

PICH

Pitch Pit – this stinks

 

GEX

Georgina Energy: Lyin’ Yet again

Time left: 13:15:34